Ghias Babar 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Ghias Babar
CFO & Head of Corp Development
Transactions
- Award
Common Stock
2025-12-17+121,700→ 268,700 total - Award
Emp. Stock Option (Right to Buy)
2025-12-17+355,050→ 355,050 totalExercise: $7.13From: 2026-12-17Exp: 2035-12-17→ Common Stock (355,050 underlying)
Footnotes (2)
- [F1]Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.